Lan Zhao
Overview
Explore the profile of Lan Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
365
Citations
6248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Zhou S, Yan Y, Wu L, Yuan X, Hu M, et al.
Clin Lung Cancer
. 2025 Mar;
PMID: 40087057
Purpose: This study aimed to investigate the risk factors for severe radiation pneumonitis (RP) after thoracic radiotherapy (RT) in patients with locally advanced non-small cell lung cancer (NSCLC), develop a...
2.
Saeed M, Elsadek M, Chen Z, Zhao L, Wang G, Zhou C, et al.
Food Chem
. 2025 Mar;
479:143784.
PMID: 40081069
Chinese bayberry fruit is rich in bioactive compounds which are beneficial to health. Fruit hybridization can improve quality and metabolite content, but this has yet to be explored in bayberry....
3.
Tang L, Wu J, Cao Z, Hong Q, Lin F, Tan N, et al.
Carbohydr Polym
. 2025 Mar;
356:123404.
PMID: 40049975
In this study, a novel proton-conducting film was strategically engineered by interfacial manipulation of green and sustainable biomass resources guanine and phosphorylated cellulose nanocrystals (PCNCs) within vermiculite layers. The interfacial...
4.
Zhao L, Cunningham C, Hong J, Agarwal S, Yuan K, de Jesus Perez V, et al.
Am J Respir Cell Mol Biol
. 2025 Feb;
PMID: 39928415
Pulmonary hypertension (PH) is a life-threatening disease characterized by pulmonary vascular remodeling and right ventricle (RV) dysfunction. Among the five PH groups, group 1 pulmonary arterial hypertension (PAH) is a...
5.
Zhao L, Ma G
J Chromatogr A
. 2025 Feb;
1744:465721.
PMID: 39893916
The biopharmaceutical industry has been one of the most dynamic industries in the world. New biopharmaceuticals are constantly developed, especially for complex and super-large biomolecules including antibodies, virus-like particles (VLPs),...
6.
Chang J, Yin X, Zhang M, Liu J, Zhao L
World J Stem Cells
. 2025 Jan;
17(1):101161.
PMID: 39866899
Peripheral nerve injury (PNI) is a common disease that is difficult to nerve regeneration with current therapies. Fortunately, Zou demonstrated the role and mechanism of bone marrow derived mesenchymal stem...
7.
Zhang Z, Shan X, Liang C, Zhao L, Shan X
World J Stem Cells
. 2025 Jan;
17(1):101036.
PMID: 39866898
Pulmonary fibrosis significantly contributes to the pathogenesis of acute respiratory distress syndrome (ARDS), markedly increasing patient mortality. Despite the established anti-fibrotic effects of mesenchymal stem cells (MSCs), numerous challenges hinder...
8.
Ferreira E, Oliveira R, Salomao R, Brunialti M, Cardoso M, Chen C, et al.
Infect Dis Rep
. 2025 Jan;
17(1.
PMID: 39846709
Background: Glucagon-like peptide-1 (GLP-1) agonists are an existing treatment option for patients with insulin-resistant states, which elicit further pleiotropic effects related to immune cell recruitment and vascular inflammation. GLP-1 agonists...
9.
Zhou J, Wei J, Wang H, Li H, Zhao L, Fu R, et al.
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766889
The genetic quality of laboratory mice may have a direct impact on the results of research. Therefore, it is essential to improve genetic monitoring methods to guarantee research quality. However,...
10.
Zeng M, Hu Y, Zhao L, Duan C, Wu H, Xu Y, et al.
Eur J Med Chem
. 2024 Dec;
284():117200.
PMID: 39733482
Dysregulated activation of the PI3K/AKT/mTOR pathway is crucial in the development of cancer, and disrupting it could potentially lead to cancer suppression, making it a viable strategy for cancer treatment....